|  Help  |  About  |  Contact Us

Publication : Phosphorylation state-dependent modulation of spinal glycine receptors alleviates inflammatory pain.

First Author  Acuña MA Year  2016
Journal  J Clin Invest Volume  126
Issue  7 Pages  2547-60
PubMed ID  27270175 Mgi Jnum  J:237146
Mgi Id  MGI:5811198 Doi  10.1172/JCI83817
Citation  Acuna MA, et al. (2016) Phosphorylation state-dependent modulation of spinal glycine receptors alleviates inflammatory pain. J Clin Invest 126(7):2547-60
abstractText  Diminished inhibitory neurotransmission in the superficial dorsal horn of the spinal cord is thought to contribute to chronic pain. In inflammatory pain, reductions in synaptic inhibition occur partially through prostaglandin E2- (PGE2-) and PKA-dependent phosphorylation of a specific subtype of glycine receptors (GlyRs) that contain alpha3 subunits. Here, we demonstrated that 2,6-di-tert-butylphenol (2,6-DTBP), a nonanesthetic propofol derivative, reverses inflammation-mediated disinhibition through a specific interaction with heteromeric alphabetaGlyRs containing phosphorylated alpha3 subunits. We expressed mutant GlyRs in HEK293T cells, and electrophysiological analyses of these receptors showed that 2,6-DTBP interacted with a conserved phenylalanine residue in the membrane-associated stretch between transmembrane regions 3 and 4 of the GlyR alpha3 subunit. In native murine spinal cord tissue, 2,6-DTBP modulated synaptic, presumably alphabeta heteromeric, GlyRs only after priming with PGE2. This observation is consistent with results obtained from molecular modeling of the alpha-beta subunit interface and suggests that in alpha3betaGlyRs, the binding site is accessible to 2,6-DTBP only after PKA-dependent phosphorylation. In murine models of inflammatory pain, 2,6-DTBP reduced inflammatory hyperalgesia in an alpha3GlyR-dependent manner. Together, our data thus establish that selective potentiation of GlyR function is a promising strategy against chronic inflammatory pain and that, to our knowledge, 2,6-DTBP has a unique pharmacological profile that favors an interaction with GlyRs that have been primed by peripheral inflammation.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

6 Bio Entities

0 Expression